Pain and fatigue in systemic sclerosis: Practical strategies for non-pharmacological management

Allanore Y Simms R Distler O , et al Systemic sclerosis. Nat Rev Dis Primers 2015; 1: 15002.

Devgire V Hughes M. Raynaud’s phenomenon. Br J Hosp Med 2019; 80: 658–664.

Del Galdo F Lescoat A Conaghan PG , et al EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis 2025; 84: 29–40.

Denton CP De Lorenzis E Roblin E , et al The 2024 British society for rheumatology guideline for management of systemic sclerosis. Rheumatology 2024; 63: 2956–2975.

Di Donato S McMahan ZH Hughes M . Systemic pharmacotherapy approaches for the treatment of systemic sclerosis. Expert Opin Pharmacother 2025; 26(5): 551–566.

Hughes M Zanatta E Sandler RD , et al Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study. Rheumatology 2022; 61: 2755–2769.

Basta F Afeltra A Margiotta DPE . Fatigue in systemic sclerosis: a systematic review. Clin Exp Rheumatol 2018; 36 suppl 113: 150–160.

Schieir O Thombs BD Hudson M , et al Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res 2010; 62(3): 409–417.

Baron M Bernier P Côté LF , et al Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clin Exp Rheumatol 2010; 28(2 suppl 58): S42–S46.

Dures E Farisoğulları B Santos EJF , et al 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases. Ann Rheum Dis 2024; 83: 1260–1267.

Stöcker JK Schouffoer AA Spierings J , et al Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis. Rheumatology 2022; 61: 1476–1486.

Santos EJF Farisogullari B Dures E , et al Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases. RMD Open 2023; 9: e003350.

Parodis I Girard-Guyonvarc’h C Arnaud L , et al EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis 2024; 83: 720–729.

Ostojic P Jankovic K Djurovic N , et al Common causes of pain in systemic sclerosis: frequency, severity, and relationship to disease status, depression, and quality of life. Pain Manag Nurs 2019; 20(4): 331–336.

Sandler RD Matucci-Cerinic M Hughes M. Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum 2020; 50(2): 329–334.

Malcarne VL Hansdottir I McKinney A , et al Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. J Rheumatol 2007; 34(2): 359–367.

Clements P. Management of musculoskeletal involvement in systemic sclerosis. Curr Treatm Opt Rheumatol 2016; 2(1): 61–68.

Vera-Lastra O Hernadez PB Sánchez Rodríguez-A , et al AB0991 prevalence of fibromyalgia and depression in patients with autoimmune /inflammatory syndrome induced by adjuvants compared to patients with systemic sclerosis. Ann Rheum Dis 2017; 76: 1401–1401.

Asif S Khan A Faiq M , et al Clinical and serological characteristics of systemic sclerosis: experience of a tertiary care center in Pakistan. Arch Rheumatol 2021; 36(4): 587–594.

Perrot S Peixoto M Dieudé P , et al Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria. Clin Exp Rheumatol 2017; 35 suppl 105(3): 35–42.

El-Rabbat M S Mahmoud NK Gheita TA. Clinical significance of fibromyalgia syndrome in different rheumatic diseases: relation to disease activity and quality of life. Reumatol Clin 2018; 14(5): 285–289.

Evers C Jordan S Maurer B , et al Pain chronification and the important role of non-disease-specific symptoms in patients with systemic sclerosis. Arthritis Res Ther 2021; 23: 34.

Ayan A Hekim HH Cetin SY. Effects of fibromyalgia syndrome in patients with diffuse systemic sclerosis: evaluation with 2010 American college of rheumatology criteria set. Indian J Rheumatol 2022; 17: 129.

Cuzdan N Turk I Sarpel T , et al Neuropathic pain: is it an underestimated symptom in systemic sclerosis. Clin Rheumatol 2018; 37(7): 1845–1851.

Ivanova K Žukovs D Možeitoviča E , et al Prevalence of polyneuropathies among systemic sclerosis patients and impact on health-related quality of life. Neurol Neurochir Pol 2023; 57(2): 206–211.

Ostojic P Knezevic-Apostolski S Djurovic N , et al Neurological and electroneurography findings in patients with systemic sclerosis and symptoms of neuropathic pain in extremities. Acta Neurol Belg 2021; 121(1): 205–209.

Alcacer-Pitarch B Di Battista M Redmond AC , et al Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis. Rheumatology 2025; 64: 3635–3642.

Maltez N Choi MY Troyanov Y , et al Trigeminal neuralgia in systemic sclerosis. Semin Arthritis Rheum 2021; 51: 318–323.

Hughes M Allanore Y Chung L , et al Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol 2020; 16: 208–221.

Hughes M Herrick AL. Digital ulcers in systemic sclerosis. Rheumatology 2017; 56: 14–25.

Hughes M Snapir A Wilkinson J , et al Prediction and impact of attacks of Raynaud’s phenomenon, as judged by patient perception. Rheumatology 2015; 54(8): 1443–1447.

Mouthon L Carpentier PH Lok C , et al Ischemic digital ulcers affect hand disability and pain in systemic sclerosis. J Rheumatol 2014; 41(7): 1317–1323.

Hughes M Heal C Henes J , et al Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology 2022; 61: 1141–1147.

Li CKH Baker K Jones T , et al Safety and tolerability of subcutaneous methotrexate in routine clinical practice. Arthritis Care Res (Hoboken) 2021; 73(9): 1306–1311.

Omair MA Alahmadi A Johnson SR. Safety and effectiveness of mycophenolate in systemic sclerosis. a systematic review. PLoS ONE 2015; 10(5): e0124205.

Highland KB Distler O Kuwana M , et al Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Lancet Respir Med 2021; 9(1): 96–106.

Distler O Highland KB Gahlemann M , et al Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 2019; 380: 2518–2528.

Rirash F Tingey PC Harding SE , et al Calcium channel blockers for primary and secondary Raynaud’s phenomenon. Cochrane Database Syst Rev 2017; 12: CD000467.

Ross L McDonald J Hansen D , et al Quantifying the need for specialist palliative care management in patients with systemic sclerosis. Arthritis Care Res 2024; 76(7): 964–972.

Yakut H Özalevli S Birlik AM. Fatigue and its relationship with disease-related factors in patients with systemic sclerosis: a cross-sectional study. Turk J Med Sci 2021; 51: 530–539.

Fairley JL Hansen D Proudman S , et al The burden and determinants of fatigue in incident and prevalent systemic sclerosis. Clin Exp Rheumatol 2024; 42(8): 1669–1674.

Hughes M Harrison E Herrick AL , et al The need to accurately measure energy intake and expenditure in patients with systemic sclerosis. J Scleroderma Relat Disord 2022; 7(3): 217–223.

Cherim A Petca RC Dumitrascu MC , et al Thyroid disorders in systemic sclerosis: a comprehensive review. J Clin Med 2024; 13: 415.

Elhai M Avouac J Kahan A , et al Systemic sclerosis at the crossroad of polyautoimmunity. Autoimmun Rev 2013; 12(11): 1052–1057.

Di Molfetta IV Bordoni L Gabbianelli R , et al Vitamin D and its role on the fatigue mitigation: a narrative review. Nutrients 2024; 16: 221.

Hysa E Gotelli E Campitiello R , et al Vitamin D and muscle status in inflammatory and autoimmune rheumatic diseases: an update. Nutrients 2024; 16: 2329.

Perazzi M Gallina E Manfredi GF , et al Vitamin D in systemic sclerosis: a review. Nutrients 2022; 14: 3908.

Dhaouadi T Riahi A Ben Abdallah T , et al Vitamin D association with systemic sclerosis and its clinical features: a systematic review, meta-analysis, and meta-regression. J Scleroderma Relat Disord. Epub ahead of print 21 October 2024. DOI: 10.1177/23971983241288591.

Groseanu L Bojinca V Gudu T , et al Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur J Rheumatol 2016; 3(2): 50–55.

Milette K Hudson M Körner A , et al Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus. Rheumatology 2013; 52(9): 1715–1720.

Milette K Razykov I Pope J , et al Clinical correlates of sleep problems in systemic sclerosis: the prominent role of pain. Rheumatology (Oxford) 2011; 50(5): 921–925.

Bagheri L Kavosi H Shokouhi N , et al Sleep disorders and other medical and socio-demographic factors in systemic scleroderma. Eur J Transl Myol 2024; 34: 12183.

Sariyildiz MA Batmaz I Budulgan M , et al Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int 2013; 33(8): 1973–1979.

Gundogdu S Borekci S Atahan E , et al Increased frequency of obstructive sleep apnea in the patients with systemic sclerosis. Sleep Breath 2021; 25(1): 237–242.

Bandini G Alunno A Ruaro B , et al Significant gastrointestinal unmet needs in patients with systemic sclerosis: insights from a large international patient survey. Rheumatology 2024; 63: e92–e93.

Fairley JL Hansen D Quinlivan A , et al Frequency and implications of malnutrition in systemic sclerosis. Rheumatology 2024; 64: 1251–1260.

Assassi S Fritzler MJ Arnett FC , et al Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009; 36(10): 2250–2256.

Scheen M Dominati A Olivier V , et al Renal involvement in systemic sclerosis. Autoimmun Rev 2023; 22: 103330.

Cuomo G Iandoli C Galiero R , et al Liver involvement in patients with systemic sclerosis: role of transient elastography in the assessment of hepatic fibrosis and steatosis. Diagnostics 2023; 13: 1766.

Lorena M Bellan M Lepore M , et al Clinical relevance of liver involvement in the clinical course of systemic sclerosis. J Clin Med 2022; 11: 966.

Thombs BD Bassel M McGuire L , et al A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatology 2008; 47(10): 1559–1563.

Kwakkenbos L Levis B Henry RS , et al Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participants. Rheumatology 2024; 64: 2810–2820.

Milette K Hudson M Baron M , et al Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology 2010; 49(4): 789–796.

Fairley JL Hansen D Proudman S , et al The frequency and clinical associations of opioid use in systemic sclerosis. Rheumatol Adv Pract 2024; 8(4): rkae144.

De Luca R Maresca M Orlandi M , et al The emerging challenge of pain in systemic sclerosis: similarity to the pain experience reported by Sjőgren’s syndrome patients. Rheumatol Immunol Res 2021; 2(2): 113–119.

Cengiz G Erol K Gok K , et al Comparison of pain characteristics in patients with rheumatoid arthritis and systemic sclerosis with particular reference to the neuropathic pain component: cross-sectional study. Med Princ Pract 2018; 27(6): 537–542.

Khanna D Nagaraja V Gladue H , et al Measuring response in the gastrointestinal tract in systemic sclerosis. Curr Opin Rheumatol 2013; 25(6): 700–706.

Merkel PA Herlyn K Martin RW , et al Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum 2002; 46: 2410–2420.

Kiss F Farkas N Nagy G , et al Minimal clinically important differences (MCID) for the functional assessment of chronic illness therapy fatigue scale in patients with systemic sclerosis. Int J Environ Res Public Health 2022; 20: 771.

Ibn Yacoub Y Amine B Bensabbah R , et al Assessment of fatigue and its relationships with disease-related parameters in patients with systemic sclerosis. Clin Rheumatol 2012; 31(4): 655–660.

Khanna D Denton CP Jahreis A , et al Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet 2016; 387: 2630–2640.

Iudici M Vettori S Russo B , et al Outcome of a glucocorticoid discontinuation regimen in patients with inactive systemic sclerosis. Clin Rheumatol 2016; 35(8): 1985–1991.

de Oliveira NC Portes LA Pettersson H , et al Aerobic and resistance exercise in systemic sclerosis: state of the art. Musculoskeletal Care 2017; 15(4): 316–323.

Faverzani S Nocera F Crisafulli E , et al Home-based unsupervised pulmonary rehabilitation program improves the respiratory disability in systemic sclerosis patients with dyspnea: an observational prospective study. Monaldi Arch Chest Dis 2021; 92(3): 1984.

Murphy SL Poole JL Chen YT , et al Rehabilitation interventions in systemic sclerosis: a systematic review and future directions. Arthritis Care Res (Hoboken) 2022; 74(1): 59–69.

de Alegria SG Azevedo BLPA Oliveira JGM , et al Home-based rehabilitation improves functional capacity and quality of life in women with systemic sclerosis: a preliminary study. J Back Musculoskelet Rehabil 2023; 36(2): 455–463.

Mugii N Hamaguchi Y Maddali-Bongi S. Clinical significance and usefulness of rehabilitation for systemic sclerosis. J Scleroderma Relat Disord 2018; 3(1): 71–80.

Stefanantoni K Sciarra I Iannace N , et al Occupational therapy integrated with a self-administered stretching program on systemic sclerosis patients with hand involvement. Clin Exp Rheumatol 2016; 34 suppl 100(5): 157–161.

Poole JL. Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol 2010; 22(2): 205–212.

Frade S Cameron M Espinosa-Cuervo G , et al Exercise and physical therapy for systemic sclerosis. Cochrane Database Syst Rev 2022; 2022: CD014902.

Bongi SM Del Rosso A Passalacqua M , et al Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res 2011; 63(8): 1134–1141.

Nguyen AD Andréasson K McMahan ZH , et al Gastrointestinal tract involvement in systemic sclerosis: the roles of diet and the microbiome. Semin Arthritis Rheum 2023; 60: 152185.

Smith E Pauling JD. The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2019; 49(1): 112–118.

Zhong C Qu C Wang B , et al Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence. J Clin Gastroenterol 2017; 51(4): 300–311.

Russo E Bellando-Randone S Carboni D , et al The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis. Rheumatology 2024; 63: 226–234.

Bellando-Randone S Russo E Di Gloria L , et al Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile. RMD Open 2024; 10: e004647.

Natalello G Bosello SL Campochiaro C , et al Adherence to the Mediterranean diet in Italian patients with systemic sclerosis: an epidemiologic survey. ACR Open Rheumatol 2024; 6(1): 14–20.

Haß U Herpich C Norman K. Anti-inflammatory diets and fatigue. Nutrients 2019; 11: 2315.

Barnish M Sheikh M Scholey A. Nutrient therapy for the improvement of fatigue symptoms. Nutrients 2023; 15: 2154.

Burlui AM Cardoneanu A Macovei LA , et al Diet in scleroderma: is there a need for intervention? Diagnostics 2021; 11: 2118.

Kwakkenbos L Bluyssen SJ Vonk MC , et al Addressing patient health care demands in systemic sclerosis: pre-post assessment of a psycho-educational group programme. Clin Exp Rheumatol 2011; 29(2 suppl 65): S60–S65.

Romanazzo S Ceccatelli S Mansueto G , et al Well-being therapy in systemic sclerosis outpatients: a randomized controlled trial. Rheumatology 2025; 64: 667–674.

El Aoufy K Pezzutto A Pollina A , et al Systemic sclerosis patients experiencing mindfulness-based stress reduction program: the beneficial effect on their psychological status and quality of life. Int J Environ Res Public Health 2023; 20: 2512.

Gokcen N Komac A Tuncer Kuru F , et al Inadequate sleep hygiene as a key factor in poor sleep quality in systemic sclerosis: an observational, cross-sectional study. Rheumatol Int 2025; 45: 40.

Murphy SL Barber MW Homer K , et al Occupational therapy treatment to improve upper extremity function in individuals with early systemic sclerosis: a pilot study. Arthritis Care Res 2018; 70(11): 1653–1660.

Špiritović M Šmucrová H Heřmánková B , et al The effect of a 24-week physiotherapy and occupational therapy program in systemic sclerosis: a monocentric controlled study with follow-up. Clin Exp Rheumatol 2022; 40(10): 1941–1950.

Murphy SL Barber M Huang S , et al Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trial. Rheumatology 2021; 60: 5002–5011.

Gavin JP Rossiter L Fenerty V , et al The impact of occupational therapy on the self-management of rheumatoid arthritis: a mixed methods systematic review. ACR Open Rheumatol 2024; 6(4): 214–249.

Saoji AA Das P Devi NS. Yoga therapy as an adjunct to conventional management of systemic sclerosis: a case series. J Ayurveda Integr Med 2021; 12(4): 705–709.

Sallam HS McNearney TA Chen JD. Acupuncture-based modalities: novel alternative approaches in the treatment of gastrointestinal dysmotility in patients with systemic sclerosis. Explore 2014; 10(1): 44–52.

Andrea Cortés-Ladino C Augusto Arias-Ortiz W Porras-Ramírez A . Effectiveness of yoga and acupuncture in rheumatoid arthritis: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2023; 2023: 9098442.

Sagtaganov Z Yessirkepov M Bekaryssova D. Yoga as a complementary therapy for rheumatoid arthritis: a case-based review. Rheumatol Int 2024; 44(8): 1575–1579.

Nagy S Tague K Ossorio A , et al The effects of yoga on the mental health of individuals with autoimmune disorders: a scoping review. Cureus 2025; 17(1): e77669.

Sallam H McNearney TA Doshi D , et al Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci 2007; 52(5): 1329–1337.